Invivyd to Host Conference Call to Announce Results from Interim Analysis of Phase 3 DECLARATION Clinical Trial on November 23, 2026
Investor call to be held at 8:30 a.m.
Fastest customizable press release feed in the world.
Signed out · Sign up for real-time
Updates arrive automatically.
Investor call to be held at 8:30 a.m.
Defiance ETFs today announced that its two 2X daily Anthropic ETFs, the Defiance 2X ANT Long Daily ETF (NASDAQ:ANTC) and the Defiance 2X ANT Short Daily ETF (NASDAQ:ANTQ), begin trading on The Nasdaq Stock Market tomorrow, Monday, November 23, 2026, at the 9:30 a.m. ET open. The two leveraged single-stock ETFs, one long and one inverse, are tied to the share price of Anthropic (NASDAQ:ANT), the AI company behind Claude, whose stock began trading on Nasdaq on November 19, 2026. Key Facts What: ANTC is a daily 2X long Anthropic ETF and ANTQ is a daily 2X short Anthropic ETF, both from Defiance ETFs. When: Trading begins Monday, November 23, 2026, at
With Anthropic now trading on Nasdaq (ticker: ANT), Leverage Shares by Themes outlines three ways investors can take a bearish view on Anthropic stock, including planned 2X Short (ANDD) and 1X Short (ANSS)
At the Nanchang round of the China Urban Intelligent Driving Competition, the 2027 AION i60, equipped with WeRide’s WRD 3.0 one-stage end-to-end Advanced Driver Assistance System (ADAS) solution, claimed the championship, delivering an outstanding performance with the only zero-takeover result across all competitors. This landmark victory made WeRide the competition’s first and only nine-time champion. The achievement was further underscored in the preliminary round, where the GAC Trumpchi YUE7 and 2027 AION i60, both equipped with WRD 3.0, delivered the only two scores exceeding 100 points across all competitors, securing first and secon
Late-breaking 1-year data in 100 patients presented at PCR London Valves 2026: No moderate or severe paravalvular leak, 96% in NYHA class I/II and 97% free from moderate or severe prosthesis-patient mismatch at 30 days
Following Anthropic's $83-per-share IPO pricing and Nasdaq trading debut at $111.50-per-share on November 19, 2026, Leverage Shares by Themes outlines how investors can gain long exposure to Anthropic stock (ANT), and where its planned 2X Long Anthropic ETF (ANUU) fits into the investment landscape.
Celebrating 40 years of GIGABYTE, GIGABYTE has partnered with Newegg to host AORUS VS40, a free community gaming celebration taking place on Saturday, November 21, 2026, from 11 a.m. to 4 p.m. PST at the Newegg Gamer Zone in Diamond Bar, California. The event invites local collegiate PC gamers, esports fans, and hardware enthusiasts to mark GIGABYTE's 40-year milestone with competitive esports tournaments, hands-on hardware challenges, and exclusive gear. Under the theme "PLAY. WIN. MAKE IT YOURS.", AORUS VS40 features high-energy 1v1 competitions in VALORANT and League of
Company receives Complete Response Letter from FDA for Deramiocel BLAConference call and webcast Monday, November 23, at 8:30 a.m.
In the news release, Sidus Space Expands Aerospace Customer Base with Argotec Order, issued 19-Nov-2026 by Sidus Space, Inc. over PR Newswire, we are advised by the company that the image has been updated. The complete, corrected release follows:Sidus Space Expands Aerospace Customer Base with Argotec OrderSidus extends nearly 15 years of aerospace manufacturing, proven on its own LizzieSat satellites in orbit, to a new international customer.
JBS N.V. (the "Company," "JBS," "we" or "us") (NYSE:JBS, B3: JBSS32)), together with JBS USA Foods Group Holdings, Inc. and JBS USA Food Company Holdings (collectively, the "Co-Issuers"), announced today the expiration and results of its previously announced offers to exchange (the "Exchange Offers") any and all of the outstanding Old Notes (as defined below) for an equal principal amount of new notes (the "New Notes") in a transaction registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"). The Exchange Offers expired at 5:00 p.m., New York City time, on November 20, 2026 (the "Expiration Date"). As of
MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) (the "Company") today announced that it received written notice dated November 20, 2026, from Nasdaq Listing Qualifications confirming that the Company has regained compliance with the periodic filing requirement under Nasdaq Listing Rule 5250(c)(1), because the Company filed its Form 20-F for the year ended December 31, 2025 on November 18, 2026. Accordingly, Nasdaq has closed the matter relating to the delayed filing of the Company’s annual report. The Company remains subject to the previously disclosed minimum bid price deficiency under Nasdaq Listing Rule 5550(a)(2) and has until April 5, 2027 t
Surgery Partners, Inc. ("Surgery Partners") (NASDAQ:SGRY) announced today the results of the previously announced solicitation of consents (the "Consent Solicitation") by its indirect wholly owned subsidiary, Surgery Center Holdings, Inc. (the "Issuer"), from holders ("Holders") of its outstanding $1,225,000,000 aggregate principal amount of 7.250% Senior Notes due 2032 (CUSIP Nos. 86881W AF9 / U86786 AD9 / U86786 AE7; ISINs US86881WAF95 / USU86786AD98 / USU86786AE71) (the "Notes") to certain proposed amendments (the "Proposed Amendments") to the indenture governing the Notes, dated as of April 10, 2024 (as supplemented, the "Indenture"),
Univest Securities, LLC ("Univest"), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a best-efforts public offering (the "Offering") of $5.0 million for its client Fitness Champs Holdings Limited (NASDAQ:FCHL) (the "Company" or "Fitness Champs"), a distinguished aquatic sports education provider in Singapore. The Offering is comprised of 14,285,715 units (each, a "Unit"), consisting of one Class A ordinary share of the Company, par value $0.00225 per share (the "Class A Ordinary Shares"), or in lieu thereof, a pre-funded warrant, and one warrant to
Four Corners Property Trust (NYSE:FCPT), a real estate investment trust primarily engaged in the ownership and acquisition of high-quality, net-leased restaurant and retail properties ("FCPT" or the "Company"), is pleased to announce the acquisition of a Vive Collision property for $3.9 million. The property is located in a strong retail corridor in New Jersey and corporate-operated under a long-term, triple net lease with approximately 19 years of term remaining. The transaction was priced at a 6.9% cap rate on rent as of the closing date and exclusive of transaction costs. About FCPT FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the own
Alps Group Inc ("Alps" or "the Company") (NASDAQ:ALPS), an integrated biotechnology platform headquartered in Malaysia, today announced that it has received written notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has regained compliance with the minimum bid price requirement for continued listing on The Nasdaq Global Market. On May 19, 2026, the Company previously disclosed that, on May 15, 2026, the Company received a letter from Nasdaq notifying the Company that based on the closing bid price of the ordinary shares of the Company for the prior 30 consec
Third-quarter revenue of $11.2 million increased from $8.2 million in the second quarter; year-over-year results continued to reflect lower residential demand following the expiration of the Section 25D federal residential tax credit. Commercial revenue increased 20% year-over-year to $2.7 million; SG&A expense declined 37% year-over-year to $4.3 million. Results included $9.8 million of non-cash goodwill and intangible asset impairment charges. SUNation continues to prioritize liquidity, cost management, and execution of its proposed merger with
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) ("Iovance" or the "Company"), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ("TIL") therapies for patients with cancer, today announced that on November 19, 2026 (the "Date of Grant"), the Company approved the grant of inducement stock options covering an aggregate of 175,840 shares of Iovance’s common stock to twenty-two new, non-executive employees. The awards were granted under Iovance’s Amended and Restated 2021 Inducement Plan, which provides for the granting of equity awards to new employees of Iovance by th
Brainstorm Cell Therapeutics Inc. (OTCQB:BCLI) has released the following notice. The full Notice of Pendency and Proposed Settlement of Stockholder Derivative Matters and the Stipulation and Agreement of Settlement, with its exhibits, are available at https://brainstorm-cell.com/investors/ . UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK IN RE BRAINSTORM CELL THERAPEUTICS, INC. DERIVATIVE LITIGATION Lead Case No. 1:24-cv-01095-DEHSUMMARY NOTICE OF PENDENCY AND PROPOSED SETTLEMENT OF STOCKHOLDER DERIVATIVE MATTERSEXHIBIT D TO: ALL RECORD HOLDERS AND BENEFICIAL OWNERS OF BRAINSTORM CELL THERAPEUTICS INC. ("BRAINSTORM" OR THE "COMP
Barrick Mining Corporation (NYSE:B)(TSX:ABX) has received notice of an unsolicited mini-tender offer made by New York Stock and Bond LLC ("NYSB") to purchase up to 50,000 of Barrick’s common shares at a below-market price of US$26.40 per share. NYSB’s below-market offer price of US$26.40 per share represents a discount of approximately 34.91% to the closing price of Barrick common shares on the New York Stock Exchange on November 6, 2026, the last trading day before the mini-tender offer was commenced. Barrick shareholders who tender their shares in this offer will receive a below-market price. Barrick recommends shareholders do not tender their
Power Integrations (Nasdaq: POWI) today announced that on November 15, 2026 (the Grant Date), it granted a total of 42,411 RSUs and 1,361 PSUs at target to a total of 15 employees who began their employment with Power Integrations in October 2026. The inducement grants were issued pursuant to Power Integrations’ Amended and Restated 2025 Inducement Award Plan. One-fourth (1/4th) of the RSUs will vest on each of the first four anniversaries of the respective Grant Dates, subject to the recipient’s continued service through each applicable vesting date. The PSUs will vest based upon achievement of the Company’s performance metrics for 2026, as determined by the Talent and Compensation Committee